Crystalvue Medical Corporation (TPEX:6527)
77.00
+2.50 (3.36%)
At close: Mar 6, 2026
Crystalvue Medical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 132.02 | 241.64 | 273.35 | 176.55 | 193.78 |
Cash & Short-Term Investments | 132.02 | 241.64 | 273.35 | 176.55 | 193.78 |
Cash Growth | -45.37% | -11.60% | 54.83% | -8.89% | -57.25% |
Accounts Receivable | 243.95 | 187.09 | 124.24 | 160.79 | 110.37 |
Other Receivables | - | - | - | 1.9 | 0.03 |
Receivables | 243.95 | 187.09 | 124.24 | 162.69 | 110.4 |
Inventory | 253.69 | 260.1 | 286.2 | 257 | 195.83 |
Prepaid Expenses | 11.27 | 11.03 | 9.32 | 11.39 | 11.17 |
Other Current Assets | - | - | 3.01 | 2 | 7 |
Total Current Assets | 640.92 | 699.86 | 696.13 | 609.63 | 518.17 |
Property, Plant & Equipment | 638.71 | 470.12 | 366.51 | 390.23 | 408.07 |
Long-Term Investments | 3.6 | 3.6 | 3.6 | 3.97 | 3.38 |
Other Intangible Assets | 2.69 | 3.9 | 4.82 | 1.73 | 1.03 |
Long-Term Deferred Tax Assets | 4.34 | 2.47 | 2.01 | 1.81 | 2.16 |
Other Long-Term Assets | 5.02 | 4.95 | 5.36 | 5.62 | 5.7 |
Total Assets | 1,295 | 1,185 | 1,078 | 1,013 | 938.51 |
Accounts Payable | 89.85 | 90.26 | 69.2 | 68.75 | 52.19 |
Accrued Expenses | - | 47.4 | 38.02 | 35.25 | - |
Current Portion of Leases | 6.96 | 6.76 | 6.01 | 6.38 | 6.2 |
Current Income Taxes Payable | 31.05 | 25.15 | 31.2 | - | - |
Current Unearned Revenue | 3.33 | 16.86 | 15.23 | 13.76 | 12.45 |
Other Current Liabilities | 129.95 | 46.78 | 41.79 | 85.89 | 117.35 |
Total Current Liabilities | 261.14 | 233.22 | 201.45 | 210.03 | 188.19 |
Long-Term Leases | 4.75 | 11.7 | 19.02 | 25.03 | 31.41 |
Long-Term Deferred Tax Liabilities | 0.91 | 1.47 | 0.9 | 2.26 | - |
Total Liabilities | 266.79 | 246.39 | 221.37 | 237.32 | 219.61 |
Common Stock | 254.59 | 254.59 | 254.59 | 242.76 | 242.76 |
Additional Paid-In Capital | 215.18 | 215.18 | 212.95 | 200.04 | 200.04 |
Retained Earnings | 572.28 | 482.32 | 407.46 | 372.85 | 304.12 |
Treasury Stock | -6.58 | -6.58 | -10.96 | -33.01 | -21.04 |
Comprehensive Income & Other | -6.97 | -6.97 | -6.97 | -6.97 | -6.97 |
Shareholders' Equity | 1,028 | 938.53 | 857.06 | 775.66 | 718.9 |
Total Liabilities & Equity | 1,295 | 1,185 | 1,078 | 1,013 | 938.51 |
Total Debt | 11.7 | 18.46 | 25.03 | 31.41 | 37.61 |
Net Cash (Debt) | 120.31 | 223.18 | 248.32 | 145.14 | 156.17 |
Net Cash Growth | -46.09% | -10.12% | 71.09% | -7.06% | -61.88% |
Net Cash Per Share | 4.67 | 8.69 | 9.82 | 5.69 | 6.16 |
Filing Date Shares Outstanding | 25.34 | 25.34 | 25.26 | 24.83 | 25.06 |
Total Common Shares Outstanding | 25.34 | 25.34 | 25.26 | 24.83 | 25.06 |
Working Capital | 379.79 | 466.65 | 494.68 | 399.6 | 329.98 |
Book Value Per Share | 40.59 | 37.03 | 33.92 | 31.23 | 28.69 |
Tangible Book Value | 1,026 | 934.63 | 852.24 | 773.93 | 717.87 |
Tangible Book Value Per Share | 40.48 | 36.88 | 33.73 | 31.16 | 28.65 |
Land | - | 312.35 | 312.35 | 312.35 | 312.35 |
Machinery | - | 271.32 | 140.93 | 136.91 | 129.43 |
Leasehold Improvements | - | 17.07 | 17.01 | 16.68 | 16.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.